These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Plasmapheresis in neurological diseases]. Oikarinen R Duodecim; 1990; 106(7):553-4. PubMed ID: 1670211 [No Abstract] [Full Text] [Related]
6. The utility of therapeutic plasmapheresis for neurological disorders. Natl Inst Health Consens Dev Conf Consens Statement; 1986; 6(4):1-7. PubMed ID: 3537747 [No Abstract] [Full Text] [Related]
7. [Therapeutic plasma exchange for neuroimmunological disorders]. Shibuya N No To Shinkei; 1993 Oct; 45(10):925-32. PubMed ID: 8268032 [No Abstract] [Full Text] [Related]
8. [Clinical application and the technical procedure of plasmapheresis]. Gurland HJ; Samtleben W Internist (Berl); 1983 Jan; 24(1):14-26. PubMed ID: 6341277 [No Abstract] [Full Text] [Related]
9. [Clinical study on therapeutic plasmapheresis--mechanism of its efficacy, indications, and the clinical application. k. Nervous system diseases]. Sato T; Utsumi H; Kagamihara Y Nihon Rinsho; 1984 Aug; 42(8):1908-13. PubMed ID: 6513058 [No Abstract] [Full Text] [Related]
10. The utility of therapeutic plasmapheresis for neurological disorders. NIH Consensus Development. JAMA; 1986 Sep; 256(10):1333-7. PubMed ID: 3747048 [No Abstract] [Full Text] [Related]
14. [Plasmapheresis as a method of intensive care in neurology]. Piradov MA Anesteziol Reanimatol; 1996; (2):92-4. PubMed ID: 8754188 [No Abstract] [Full Text] [Related]
16. [Treatment of generalized myasthenia using therapeutic plasmapheresis (review of the literature)]. Sapin SM; Marchuk AI; Golovteev VV Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(10):1574-9. PubMed ID: 3544616 [No Abstract] [Full Text] [Related]
19. [Results of treatment with plasmapheresis in myasthenic crisis and severe polyneuropathy]. Usnarska-Zubkiewicz L; Bilińska M; Gruszka E Pol Arch Med Wewn; 1991 Dec; 86(6):416-9. PubMed ID: 1819792 [TBL] [Abstract][Full Text] [Related]